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Abstract
Aerial parts of Eclipta alba are used traditionally for the treatment of several diseases of liver, skin and 
stomach. Methanolic extract and active principle compound of a well known Indian hepatoprotective herb, 
Eclipta alba was tested for in vitro antimicrobial studies. It was evaluated using zone of inhibition studies 
and minimum inhibitory concentration. The extract exhibited activity against all six strains studied. 
Phytochemical screening of the extract revealed the presence of tannins, flavonoids, coumestans, saponins 
and alkaloids etc. Ethylacetate fraction and further pure isolated wedelolactone showed enhanced 
antimicrobial activity. Staphylococcus epidermidis, Staphylococcus aureus and Salmonella typhimurium were 
most susceptible. Shigella flexneri was the most resistant bacterial strain. These results suggest 
coumestans/wedelolactone as a promising antimicrobial agent.
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Introduction
Modern medicine has evolved from folk medicine and traditional system only after thorough chemical 
and pharmaceutical screening. The use of synthetic compounds led to a decline in the use of plants in 
modern medicine. However, synthetic medicine can cause side effects and as a result people are more favorable to 
use natural compounds obtained from plants. Thus, plants remain a major source of medicinal compounds. 
About 20,000 plant species are used for medicinal purposes (Penos, 1983). Seventy four percent of 119 plant-
derived drugs were discovered as a result of chemical studies to isolate the active substances responsible for 
their traditional use (Farnsworth and Soejarto, 1991). So plants, especially the higher plants contain a variety 
of substances, which are useful as food additives, perfumes, and in treatment of various diseases as medicine due 
to their versatile therapeutic potential (Mukherjee and Wahile, 2006). The active secondary metabolites 
possess various medicinal applications as drugs or as model compounds for drug synthesis. Phytochemical analysis 
of plants, used in folklore has yielded a number of compounds with various pharmacological activities. In view of 
the increasing development of resistant microorganisms, treatment of various diseases caused by microorganisms 
has become a major challenge in the human medical field. This may be due on the one hand, to the synthetic nature 
of these substances, but also to their known side effects and in some cases to their unpleasant smell, taste or 
the burning sensation felt on the skin. Medicinal plants are important substances for the study of their traditional 
uses through the verification of pharmacological effects and can be natural composite sources that act as new 
anti-infectious agents. About 3,000 materials from 2,764 plant species have been screened for their 
pharmacological and chemotherapeutic properties (Anon, 1988). India, in particular has yielded an incredible array 
of plant products that have drawn the attention of ethno pharmacologists from around the world. Traditionally 
used medicinal plants produce a variety of compounds of known therapeutic properties (Iyengar, 1976; 
Harborne, 1989; Chopra et al., 1992). 
Various biological activities are possessed by E. alba, such as memory disorders treatment, general tonic, 
edema, fevers and rheumatic joint pains treatment, digestion, hepatitis, enlarged spleen, antioxidant activity and 
skin disorders (Chopra et al., 1956; Karnick and Kulkarni, 1990; Karthikumar et al., 2007). Wedelolactone is 
active principle compound of this liver disorder treating drug (Wagner et al., 1986). It also exhibits Trypsin 
inhibitory effect (Samiulla et al., 2003; Syed et al., 2003), suppresses LPS-induced caspase-11 expression in 
cultured cells by directly inhibiting the IKK complex (Kobori et al., 2004), treatment of cirrhosis of the liver 
and infectious hepatitis (Murphy et al., 1979). The shoot extract of E. alba showed antimicrobial (Anonymous 
1952; Kosuge et al., 1985; Wiart et al., 2004), antifungal activity (Venkatesan and Ravi, 2004) and weak 
cytotoxicity against the M-109 cell lines by alkaloids Verazine (Abdal Kadar et al., 1998), antiviral activity 
against Ranikhet disease virus (Khin et al., 1978), effective against internal and external parasites (Lans et al., 
2001) G. intestinalis (Sawangjaroen et al., 2005), antibacterial (Kumar et al., 2007). Since E. alba is a weed /
herb growing in dump, moist puddles distributed in the tropical and subtropical regions of the world. So 
besides ethnobotanical evidence, it can be hypothesized that plants which survive in media rich in microbes 
most likely be possessing antimicrobial principles.
However, up to date, research has been done to investigate various pharmacological activities and 
antimicrobial activity of only crude extracts of this traditionally used herb. We report here our findings on 
antibacterial effects of wedelolactone (Fig. 1), the principle active compound, extracted from E. alba.
 
 
 
Figure 1. Chemical structure of Wedelolactone (R1-OH, R2-CH3).
 
Materials and Methods
Collection of plant material 
Plants of E. alba were collected locally from botanical garden and surroundings of Maharshi Dayanand 
University, Rohtak. The plant was duly authenticated and voucher specimens (EA-06/) were deposited in 
the herbarium section, Dr Jaya Parkash Yadav, of Department of Biosciences, Maharshi Dayanand University, 
Rohtak (Haryana) India.
 
Qualitative estimation of primary and secondary plant metabolites 
All estimations were done following Hunda et al. (1985); Brindha et al. (1981).Different aerial parts of the plant 
were dried at room temperature, powered, and extracted with methanol (70% v/v) in Soxhlet apparatus for six 
hours. The extract was filtered and was tested with different alkaloid reagents.
 
Methanol extract
 The three months old 950 gm lyophilized leaves were Soxhlet extracted with methanol for 36 h.
 
Ethyl acetate fraction
 The methanol was removed from extract and the residues were suspended in water separately and heated on 
steam bath below 80 °C for 30 min. After filtration, the aqueous phase was partitioned with ethyl acetate. The 
organic phase was dried, filtered and the solvents were evaporated to yield 6.8 gm light brown powder.
 
 Isolation of Wedelolactone
The powder was subjected to fractionation by column chromatography on silica gel, eluted with the solvent 
of increased polarity i.e. Non-polar - polar - highly polar. The coumestans are polar compounds so the 
solvent combination found suitable for their elution was Chloroform + Methanol (70 + 30). They were 
eluted simultaneously in 37 to 48 fractions. The pooled sample was then subjected to TLC, the solvent 
system (Toluene : Acetone : Formic acid :: 11 : 6 : 1 v/v) showed two spots with Rf values 0.39 and 0.28 
which matched with the Rf values of reference wedelolactone and demethylwedelolactone respectively (Courtesy M/
s Natural Remedies, Bangalore, India). The purified sample of wedelolactone was put to HPLC for further 
qualitative analysis using instrument - Thermo Finnigan from Thermo Electron Corp. USA, with quaternary pump 
and online degasser system with Auto sampler equipped with Photo Diode Array (PDA) detector, 
ChromQuest Version 5.0 for data interpretation and Supleco C8 Discovery column, 15 cm x 4.6 mm, Lot No. 
59353 (Fig. 2).
 
 
              
Figure 2. The chromatogram of extract showing the peak.
 
Preparation of samples for testing
The zone of inhibition studies were conducted with various extracts diluted with 10% dimethylsulfoxide (DMSO). 
 
Micro organisms
 Standardized strains from the American/Microbial type culture collection were used in bioassays. 
Staphylococcus aureus (ATCC 9144), Salmonella typhimurium (ATCC 23564), Escherichia coli (ATCC 
10536), Staphylococcus epidermidis (ATCC 155), Shigella flexneri (ATCC 29508) and Pseudomonas 
aeruginosa (ATCC 25668) were cultured at 37 °C on nutrient medium in aerobic conditions for 24 h. These 
bacteria were obtained from the Institute of Microbial Technology, Chandigarh.
Antimicrobial susceptibility testing
 MIC of wedelolactone was determined by microdilution technique as described by the National Committee 
for Clinical Laboratories standards (2000). The MIC was defined as the lowest concentration of the compound 
to inhibit the growth of microorganism. The bacteria inoculums were prepared in 5 ml nutrient broth and incubated 
at 37°C. The final inoculums were of approximately 5 x 106 CFU/ml. Controls with 0.5 ml of culture medium with 
out the samples and other without microorganisms were used in the tests. Tubes were incubated at 37°C for 24 h. 
The activity was measured as a function of turbidity at 660 nm. Lack of turbidity was further confirmed by 
pouring suspension aliquot of 0.1 ml into pre-sterilized Petri dishes with nutrient agar medium. The tests 
were conducted in triplicate.
Agar well diffusion method was carried out by allowing perforation of extract and wedelolactone dissolved in 
DMSO at a concentration of 3.5mg/well and 10 mg/ml respectively. Petriplate containing 30 ml nutrient agar 
medium were kept for the solidification before inoculating the microorganism, desired numbers of holes of 
uniform diameter of 8mm were made after solidification, using sterile aluminum borer. 0.2 ml of compound, 
positive (Gentamycin) and negative (solvent blank) controls were poured into wells. After incubation for 24 h at 37 °
C the plates were observed and the compound activity was evaluated by measuring zone of inhibition (diameter 
mm). The tests were conducted in triplicate. Gentamycin (10.0 µg/ml) was used as positive control. The 
negative control was 10% DMSO.
Results 
The results of the presence of various primary and secondary metabolites in methanol extract (Table 1) 
reported negative for antraquinones throughout herb. Methanol extract and Ethyl acetate fraction showed positive 
signs of antimicrobial activity against all six strains (Table 2). Wedelolactone exhibited significant 
antibacterial activity against the six tested strains (Table 3). S. epidermidis and S aureus were found to be 
highly sensitive. The MIC of S. epidermidis, S. typhimurium, S. aureus, P. aeruginosa, S. flexneri and E. coli was, 
15 µg/ml, 25 µg/ml, 20µg/ml, 1250 µg/ml ,1300 µg/ml and 1000 µg/ml respectively. The compound showed 
the highest antibacterial activity (ZOI) in S. epidermidis (10.24 mm), followed by S. typhimurium (9.16 mm), S. 
aureus(9.14 mm),E.coli (8.60mm) P. aeruginosa (8.00 mm) and S. flexneri (7.60 mm) as zone of inhibition in radius. 
 
Table 1. Quantitative estimation of the various primary and secondary metabolites.
S.No. Chemical Test Natural plant extract
Leaf Stem Root
1 Alkaloids + + -
2 Coumestans + + +
3 Anthraquinones - - -
4 Phenolics + + +
5 Saponins + + +
6 Steroids + + +
7 Proteins + + +
8 Amino-acids + + +
9 Reducing sugar + + -
10 Flavonoids + + +
 
Table 2. Antibacterial activity of Methanol extract and Ethyl acetate fraction against bacterial strains.
Extracts tested Conc. mg/well E. coli S. typhimurium S. epidermidis S.aureus Shigella 
flexneri
Pseudomonas 
aeruginosa
Methanol extract 
of leaves
3.5 +
 
+++ ++++ +++ + ++
 
Ethylacetate 
fraction
3.5 +
 
+++ ++++ +++ + ++
 
Discussion                                 
The primary and secondary metabolites were analyzed in methanolic extracts. Anthraquinones were found to be 
absent in the natural plant. While the alkaloids and reducing sugars were absent in root extract of the natural plant. 
In an earlier study, the extracts of the leaves of E. alba tested positive for steroid, reducing sugars, alkaloids, 
phenolics, saponins and tannins, but no anthraquinones and flavonoids were detected (Gopalakrishan and 
Solomon, 1992).
 In Gujrat and Punjab, E. alba is used externally for ulcers and as an antiseptic for wounds in cattle and is reported 
to treat many microbial infections in rural areas (Warrier, 1994). The results from the current studies revealed that 
the wedelolactone may be the main constituent responsible for antimicrobial activity. There are various reports 
that crude extract from E. alba and E. prostrata showed antibacterial, antifungal and anti viral activity (Kosuge et 
al., 1985; Wiart et al., 2004; Venkatesan and Ravi, 2004; Khin et al. 1978; Karthikumar et al., 2007). 
Wedelolactone exhibited effective antibacterial activity against all the six strains studied. It proved highly 
effective against S. epidermidis and S. typhimurium demonstrating the specificity of wedelolactone activity. 
 
Table 3. Antibacterial activity of wedelolactone and gentamycin against bacterial strains.
Microorganisms tested ZOI (mm) MIC (µg/ml)
 A B A B
S. epidermidis 10.24 9.26 15.0 5.0
S. typhimurium 9.16 9.22 25.0 5.0
 S. aureus 9.14 9.24 20 5.0
 P.aeruginosa, 8.00 9.06 1250 2.5
S.flexneri 7.60 9.00 1300 5.0
E. coli 8.60 9.06 1000.0 5.0
MIC: minimum inhibitory concentration; ZOI: zone of inhibition (Diameter); A: wedelolactone (10.0 mg/ml); 
B: gentamycin (10.0 µg/ml); Values are mean of three replicates.
 
Karthikumar et al., (2007) reported in vitro antimicrobial activities of ethanolic extract of E. prostrate. It 
indicated good activity against S aureus 7.2mm (ZOI) and MIC 70µl/ml, and for P. aeruginosa 8.8mm (ZOI) and 
MIC 65µl/ml, at 50 µg concentration. While the present studies exhibited respective ZOI at 9.14 mm, 8.00mm 
and MIC 20 µg/ml and 1250 µg/ml respectively. Traditional reports on E. alba indicate that it is one of the herb 
used for treatment of stomach and digestion disorders, skin diseases and conjunctivitis (Poonam and Singh, 
2002).Since S. typhimurium, S.flexneri and S. aureus are pathogens responsible for stomach disorders ,while 
P.aeruginosa is common in skin flora and S. aureus is responsible for most common bacterial conjunctivitis. 
The results from the current studies revealed that the wedelolactone could be the main constituent responsible for 
these treatments as it exhibited good activity against them.
Conclusion
            On the basis of the antibacterial studies of wedelolactone, it can be suggested that this can be used 
effectively to treat S. epidermidis and S. typhimurium infections. However, the compound must be studied in 
animal models to determine the efficacy in vivo against these pathogens and to elucidate their mechanism of action. 
In vivo data may be helpful in determining the real potential usefulness of this plant for the treatment of 
infectious diseases.
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